Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung

Annals of Surgery

Volumn 252, Issue 6, 2010, Pages 1037-1043

  Al Sahaf, Osama ^a   Wang, Jiang Huai ^a   Browne, Tara J ^a   Cotter, Tom G ^a   Redmond, H Paul ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CONTROLLED STUDY; EXCISION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HISTOLOGY; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SURGICAL INJURY; TUMOR CELL; TUMOR GROWTH; WESTERN BLOTTING;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL ADHESION; DISEASE MODELS, ANIMAL; FEMALE; LUNG NEOPLASMS; MAMMARY NEOPLASMS, ANIMAL; MASTECTOMY; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 78650151050     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181efc635     Document Type: Article

References (48)

1. Baselga J, Norton L. Focus on breast cancer. Cancer Cell. 2002;1:319-322. (Pubitemid 41039134)
2. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2002;2:563-572. (Pubitemid 37328923)
3. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003;3:453-458. (Pubitemid 37328849)
4. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med. 2006;12:895-904. (Pubitemid 44175140)
5. Baker DG, Masterson TM, Pace R, et al. The influence of the surgical wound on local tumor recurrence. Surgery. 1989;106:525-532. (Pubitemid 19228613)
6. Schuh AC, Schuh AC, Keating SJ, et al. Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice. Nature. 1990;346:756-760.
7. Morgenstern L, Yamakawa T, Seltzer D. Carcinoma of the gastric stump. Am J Surg. 1973;125:29-38.
8. Watson DI. Abdominal wall metastasis after laparoscopic gastroenterostomy. Med J Aust. 1995;163:106-107.
9. Hofer SO, Shrayer D, Reichner JS, et al. Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg. 1998;133:383-389. (Pubitemid 28193522)
10. EschwegeP, Dumas F, Blanchet P, et al. Haematogenous dissemination of pro-static epithelial cells during radical prostatectomy. Lancet. 1995;346:1528-1530.
11. Yamaguchi K, Takagi Y, Aoki S, et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg. 2000;232:58-65. (Pubitemid 30456551)
12. Svendsen MN, Werther K, Nielsen HJ, et al. VEGF and tumor angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion. Scand J Gastroenterol. 2002;37:373-379. (Pubitemid 34274318)
13. Jiang WG, Puntis MCA, Hallett MB. Molecular and cellular basis of cancer invasion and metastasis: implications for treatment. Br J Surg. 1994;81:1576-1590. (Pubitemid 24349926)
14. Tyzzer E. Factors in the production and growth of tumor metastases. J Med Res. 1913;28:309-322.
15. Skipper D, Jeffrey MJ, Cooper AJ, et al. Enhanced growth of tumor cells in healing colonic anastomoses and laparotomy wounds. Int J Colorectal Dis. 1989;4:172-177. (Pubitemid 19206225)
16. Abramovitch R, Marikovsky M, Meir G, et al. Stimulation of tumor growth by wound-derived growth factors. Br J Cancer. 1999;79:1392-1398. (Pubitemid 29116795)
17. Berguer R, Bravo N, Bowyer M, et al. Major surgery suppresses maximal production of helper T-cell type 1 cytokines without potentiating the release of helper T-cell type 2 cytokines. Arch Surg. 1999;134:540-544. (Pubitemid 29218126)
18. Cohen S, Herbert TB. Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annu Rev Psychol. 1996;47:113-142. (Pubitemid 126416104)
19. Moynihan JA, Ader R. Psychoneuroimmunology: animal models of disease. Psychosom Med. 1996;58:546-558. (Pubitemid 26404819)
20. Coffey JC, Wang JH, Smith MJF, et al. Excisional surgery for cancer cure: therapy at a cost. Lancet Oncol. 2003;4:760-768. (Pubitemid 37527212)
21. Clark EA, Golub TR, Lander ES, et al. Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000;406:532-535. (Pubitemid 30625739)
22. Khanna C, Khan J, Nguyen P, et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res. 2001;61:3750-3759. (Pubitemid 32694989)
23. Kakiuchi S, Daigo Y, Tsunoda T, et al. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice. Mol Cancer Res. 2003;1:485-499. (Pubitemid 36577045)
24. Kang Y, Siegel PM, Shu W, et al. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003;3:537-549. (Pubitemid 36808649)
25. Huang S, Chen Y, Podsypanina K, et al. Comparison of expression profiles of metastatic versus primary mammary tumors in MMTV-Wnt-1 and MMTV-Neu transgenic mice. Neoplasia. 2008;10:118-124. (Pubitemid 351240877)
26. Weigelt B, Peterse JL, Van 't Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5:591-602. (Pubitemid 41081385)
27. Weigelt B, Hu Z, He X, et al. Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. Cancer Res. 2005;65:9155-9158. (Pubitemid 41507977)
28. Pulaski BA, Ostrand-Rosenberg S. Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocom-patibility complex class II and B7.1 cell-based tumor vaccines. Cancer Res. 1998;58:1486-1493. (Pubitemid 28193612)
29. Pulaski BA, Ostrand-Rosenberg S. Mouse 4T1 breast tumor model. Curr Pro-toc Immunol. 2001;4:20-21.
30. Qadri S, Wang JH, Coffey JC, et al. Surgically induced accelerated local and distant tumor growth is significantly attenuated by selective COX-2 inhibition. Ann Thorac Surg. 2004;79:990-995. (Pubitemid 40288763)
31. Pidgeon GP, Harmey JH, Kay E, etal. The role ofendotoxin/ lipopolysaccharide in surgically induced tumor growth in a murine model of metastatic disease. Br J Cancer. 1999;81:1311-1317.
32. O'Reilly MS, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell. 1997;88:277-285. (Pubitemid 28015876)
33. Smith MJ, Culhane AC, Killeen S, et al. Mechanisms driving local breast cancer recurrence in a model of breast-conserving surgery.Ann Surg Oncol. 2008;15:2954-2964.
34. Coffey JC, Wang JH, Smith MJ, et al. Phosphoinositide 3-kinase accelerates postoperative tumour growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis. Novel role for an old enemy. J Biol Chem. 2005;280:20968-20977. (Pubitemid 40805654)
35. Hofer SO, Molema G, Hermens RA, et al. The effect of surgical wounding on tumor development. Eur J Surg Oncol. 1999;25:231-243. (Pubitemid 29261281)
36. Dvorak HF. Tumors: wounds that do not heal. N Engl J Med. 1986;315:1650-1655.
37. Van Dyke T, Jacks T. Cancer modeling in the modern era: progress and challenges. Cell. 2002;108:135-144. (Pubitemid 34161134)
38. Wittwer CT, Kusukawa N. Real-time PCR. In: Persing DH, Tenover FC, Versa-lovic J, et al. eds. Molecular Microbiology: Diagnostic Principles and Practice. Washington DC: ASM Press;2004:71-84.
39. Ross DT, Scherf U, Eisen MB, et al. Systemic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000;24:227-235. (Pubitemid 30132189)
40. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science. 1996;274:998-1001. (Pubitemid 26398425)
41. Sugiyama Y, Sugiyama K, Hiari Y, et al. Microdissection is essential for gene expression profiling of clinically resected cancer tissues. Am J Clin Pathol. 2002;117:109-116. (Pubitemid 34052480)
42. Owens DM, Watt FM. Influence of beta1 integrins on epidermal squa-mous cell carcinoma formation in a transgenic mouse model: al-pha3beta1, but not alpha2beta1, suppresses malignant conversion. Cancer Res. 2001;61:5248-5254. (Pubitemid 32681560)
43. Zutter MM, Santoro SA, Staatz WD. Re-expression of the alpha2beta1 integrin abrogates the malignant phenotype of breast carcinoma cells. Proc Natl Acad Sci USA. 1995;92:7411-7415.
44. Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumourogenesis and malignant progression. Breast Cancer Res. 2001;3:289-293. (Pubitemid 32851157)
45. Sternlicht MD, Werb Z. How matrix metalloproteinase's regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463-516. (Pubitemid 33096184)
46. Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer. 2002;2:657-672. (Pubitemid 37328917)
47. Dvorak HF, Detmar M, Claffey KP, et al. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int Arch Allergy Immunol. 1995;107:233-235.
48. Coopman PJ, Do MT, Barth M, et al. The Syk tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature. 2000;406:742-747.